|
Volumn 158, Issue 8, 2001, Pages 1337-1339
|
Lithium discontinuation: Uncovering latent bipolar disorder? [11]
a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
LITHIUM;
PLACEBO;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MANIC DEPRESSIVE PSYCHOSIS;
PATIENT SELECTION;
PRIORITY JOURNAL;
PSYCHIATRIC DIAGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
TREATMENT FAILURE;
ANTIDEPRESSIVE AGENTS;
BIPOLAR DISORDER;
DEPRESSIVE DISORDER;
DRUG THERAPY, COMBINATION;
HUMANS;
LITHIUM;
LONGITUDINAL STUDIES;
PLACEBOS;
RECURRENCE;
SUBSTANCE WITHDRAWAL SYNDROME;
TREATMENT OUTCOME;
|
EID: 0034884077
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.158.8.1337 Document Type: Letter |
Times cited : (8)
|
References (0)
|